Aerska emerges from stealth to combat brain diseases with RNAi

Startup’s ‘brain shuttle’ tech is designed to efficient, repeatable delivery of genetic medicines across the blood–brain barrier. Irish biotech Aerska has emerged from stealth with $21 million in seed financing as it seeks to advance new RNA interference medicines specifically designed to reach the brain. Based in Dublin with research operations in London, the company […] The post Aerska emerges from stealth to combat brain diseases with RNAi appeared first on Longevity.Technology.